Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder

NCT00332891 ·Status: COMPLETED ·Phase: PHASE3

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)

NCT00658762 ·Status: TERMINATED ·Phase: PHASE3

Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy

NCT00121888 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

NCT00658008 ·Status: TERMINATED ·Phase: PHASE3

Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)

NCT00560612 ·Status: COMPLETED ·Phase: PHASE4

Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder

NCT00540098 ·Status: COMPLETED ·Phase: PHASE4

Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)

NCT00557622 ·Status: TERMINATED ·Phase: PHASE2

The Effects of Treatment With Sertraline for Noncardiac Chest Pain

NCT01114100 ·Status: COMPLETED ·Phase: PHASE4

Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder

NCT00836069 ·Status: TERMINATED ·Phase: PHASE3

An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

NCT00374166 ·Status: COMPLETED ·Phase: PHASE2

Special Investigation Of J Zoloft For Panic Disorder Patients

NCT00605917 ·Status: COMPLETED

Long-term Study Of Paroxetine in Women and Men

NCT00264654 ·Status: COMPLETED ·Phase: PHASE3

Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release

NCT00492414 ·Status: UNKNOWN ·Phase: PHASE4

Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder

NCT04174170 ·Status: COMPLETED ·Phase: PHASE3

Study Of Generalized Anxiety Disorder

NCT00135525 ·Status: COMPLETED ·Phase: PHASE2

A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)

NCT00735267 ·Status: TERMINATED ·Phase: PHASE3

A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder

NCT00677352 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder

NCT05260541 ·Status: TERMINATED ·Phase: PHASE2

BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder

NCT00839397 ·Status: COMPLETED ·Phase: PHASE3

Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder

NCT00025740 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder

NCT00715039 ·Status: COMPLETED ·Phase: NA

Social Anxiety Disorder Study Of Paroxetine

NCT00318669 ·Status: COMPLETED ·Phase: PHASE3

Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder

NCT00074802 ·Status: COMPLETED ·Phase: PHASE3

6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)

NCT00738738 ·Status: WITHDRAWN ·Phase: PHASE3

Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)

NCT00725725 ·Status: TERMINATED ·Phase: PHASE2